New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Ol...(whethersupplementation with chromium pic...),Health

Date:3/4/2008

whether supplementation with chromium picolinate for a 12-week period might affect brain activation under working memory task demands in 13 older adults with early memory decline. Functional magnetic resonance imaging (fMRI) scans were performed while study participants worked on a challenging cognitive task that involved holding in mind and manipulating visual information while resisting potential distractions. Results from the fMRI scans showed that subjects receiving chromium picolinate exhibited greater activation in right thalamic, right temporal, right posterior parietal and bilateral frontal regions (p = .005).

At treatment termination, urinary chromium to creatinine ratios were elevated in the chromium picolinate group (p < .0001). There was no significant difference between the groups with respect to age (72 versus 73 years), education (15.8 versus 17.3 years), mood disturbance (11 versus 4.5 Profile of Mood States score), and level of memory impairment (.89 versus .63 Clinical Dementia Rating sum boxes score).

"The earlier memory study conducted by the University of Cincinnati team in addition to the current data using functional MRI supports the ability of chromium picolinate to help improve working memory in the elderly," said James Komorowski, M.S., Vice President of Scientific Affairs at Nutrition 21. "Since chromium picolinate is one of three core components of our Core4Life Advanced Memory Formula product, we're pleased to see that ongoing research evaluating its effect on cognitive function is showing consistent beneficial results."

Study investigators used Nutrition 21's proprietary chromium picolinate found in Core4Life Advanced Memory Formula(TM), a nutritional supplement specifically formulated to improve brain health. Core4Life Advanced Memory Formula, available in soft gel form, contains chromium picolinate, phosphatidylserine (PS) and DHA. These ingredients have been scientifically tested for their ability to improve cogn
'/>"/>

SOURCE Nutrition 21, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results